Literature DB >> 31304988

Acute Changes in NADPH Oxidase 4 in Early Post-Traumatic Osteoarthritis.

Adam M Wegner1, Nestor R Campos1, Michael A Robbins2, Andrew F Haddad1, Hailey C Cunningham1, Jasper H N Yik1, Blaine A Christiansen1, Dominik R Haudenschild1.   

Abstract

Knee injuries cause structural damage and acute inflammation that initiates the development of post-traumatic osteoarthritis (PTOA). NADPH oxidase 4 (Nox4), a member of a family of enzymes that generates reactive oxygen species (ROS), plays a pivotal role in normal development of the musculoskeletal system, but may increase ROS production to harmful levels after joint injury. The role of ROS in both normal joint homeostasis and injury is poorly understood, but inhibition of excessive ROS production by Nox4 after joint injury could be protective to the joint, decreasing oxidative stress, and initiation of PTOA. Knee injuries were simulated using inflammatory cytokines in cultured primary human chondrocytes and a non-invasive mouse model of PTOA in C57BL/6N and Nox4 knockout mice. There is an acute decrease in Nox4 activity within 24 h after injury in both systems, followed by a subsequent sustained low-level increase, a novel finding not seen in any other system. Inhibition of Nox4 activity by GKT137831 was protective against early structural changes after non-invasive knee injury in a mouse model. Nox4 knockout mice had significant differences in structural and mechanical properties of bone, providing further evidence for the role of Nox4 in development of joint tissues and biochemical response after joint injury. Nox4 plays a significant role in the acute phase after joint injury, and targeted inhibition of inflammation caused by Nox4 may be protective against early joint changes in the pathogenesis of PTOA.
© 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:2429-2436, 2019. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  NADPH oxidase; Nox4; antioxidant; inflammation; joint injury; post-traumatic osteoarthritis

Mesh:

Substances:

Year:  2019        PMID: 31304988      PMCID: PMC6822680          DOI: 10.1002/jor.24417

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  33 in total

Review 1.  Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species.

Authors:  Hideki Sumimoto
Journal:  FEBS J       Date:  2008-05-30       Impact factor: 5.542

Review 2.  Therapeutic potential of NADPH oxidase 1/4 inhibitors.

Authors:  G Teixeira; C Szyndralewiez; S Molango; S Carnesecchi; F Heitz; P Wiesel; J M Wood
Journal:  Br J Pharmacol       Date:  2016-07-14       Impact factor: 8.739

3.  NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.

Authors:  Nadia Amara; Delphine Goven; Fabienne Prost; Rachel Muloway; Bruno Crestani; Jorge Boczkowski
Journal:  Thorax       Date:  2010-08       Impact factor: 9.139

4.  Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney.

Authors:  Yves Gorin; Karen Block; James Hernandez; Basant Bhandari; Brent Wagner; Jeffrey L Barnes; Hanna E Abboud
Journal:  J Biol Chem       Date:  2005-08-31       Impact factor: 5.157

5.  Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.

Authors:  Joy X Jiang; Xiangling Chen; Nobuko Serizawa; Cédric Szyndralewiez; Patrick Page; Katrin Schröder; Ralf P Brandes; Sridevi Devaraj; Natalie J Török
Journal:  Free Radic Biol Med       Date:  2012-05-19       Impact factor: 7.376

6.  NAD(P)H oxidase activity of Nox4 in chondrocytes is both inducible and involved in collagenase expression.

Authors:  Laurent Grange; Minh Vu Chuong Nguyen; Bernard Lardy; Madiha Derouazi; Yannick Campion; Candice Trocme; Marie-Helene Paclet; Philippe Gaudin; Francoise Morel
Journal:  Antioxid Redox Signal       Date:  2006 Sep-Oct       Impact factor: 8.401

7.  Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.

Authors:  M Sedeek; G Callera; A Montezano; A Gutsol; F Heitz; C Szyndralewiez; P Page; C R J Kennedy; K D Burns; R M Touyz; R L Hébert
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-14

8.  Complementary models reveal cellular responses to contact stresses that contribute to post-traumatic osteoarthritis.

Authors:  James A Martin; Donald D Anderson; Jessica E Goetz; Douglas Fredericks; Douglas R Pedersen; Bruce P Ayati; J Lawrence Marsh; Joseph A Buckwalter
Journal:  J Orthop Res       Date:  2016-08-26       Impact factor: 3.494

9.  High Rates of Osteoarthritis Develop After Anterior Cruciate Ligament Surgery: An Analysis of 4108 Patients.

Authors:  Mark E Cinque; Grant J Dornan; Jorge Chahla; Gilbert Moatshe; Robert F LaPrade
Journal:  Am J Sports Med       Date:  2017-10-06       Impact factor: 6.202

Review 10.  The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.

Authors:  Sebastian Altenhöfer; Pamela W M Kleikers; Kim A Radermacher; Peter Scheurer; J J Rob Hermans; Paul Schiffers; Heidi Ho; Kirstin Wingler; Harald H H W Schmidt
Journal:  Cell Mol Life Sci       Date:  2012-05-31       Impact factor: 9.261

View more
  5 in total

Review 1.  The evaluation of oxidative stress in osteoarthritis.

Authors:  Oana-Maria Zahan; Oana Serban; Claudia Gherman; Daniela Fodor
Journal:  Med Pharm Rep       Date:  2020-01-31

2.  ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition.

Authors:  Xiaodong Wu; Pengpeng Li; Jian Cheng; Qiang Xu; Beiji Lu; Conghui Han; Weiling Huo
Journal:  Front Bioeng Biotechnol       Date:  2021-01-28

3.  Identification of the Resveratrol Potential Targets in the Treatment of Osteoarthritis.

Authors:  Meng Zhou; Dacheng Wang; Jing Tang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-07       Impact factor: 2.629

4.  In Vivo Investigation of the Ameliorating Effect of Tempol against MIA-Induced Knee Osteoarthritis in Rats: Involvement of TGF-β1/SMAD3/NOX4 Cue.

Authors:  Hagar B Abo-Zalam; Rania M Abdelsalam; Rehab F Abdel-Rahman; Mohamed F Abd-Ellah; Mahmoud M Khattab
Journal:  Molecules       Date:  2021-11-19       Impact factor: 4.411

Review 5.  Recent Advances in Reactive Oxygen Species (ROS)-Responsive Polyfunctional Nanosystems 3.0 for the Treatment of Osteoarthritis.

Authors:  Dao-Fang Ding; Yan Xue; Xi-Chen Wu; Zhi-Heng Zhu; Jia-Ying Ding; Yong-Jia Song; Xiao-Ling Xu; Jian-Guang Xu
Journal:  J Inflamm Res       Date:  2022-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.